Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT05716425 Org: User:
Start: 02/08/23 End: 07/26/23 Due: 07/26/24

A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

Phase: N/A Priority: Normal
NCT ID: NCT05685719 Org: User:
Start: 01/04/23 End: 11/03/23 Due: 11/03/24

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05565807 Org: User:
Start: 02/09/23 End: 02/19/27 Due: 02/19/28

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT05947344 Org: User:
Start: 12/08/23 End: 12/31/25 Due: 12/31/26

[14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05754411 Org: User:
Start: 05/15/23 End: 11/09/23 Due: 11/09/24

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT05523739 Org: User:
Start: 09/16/22 End: 03/29/23 Due: 03/29/24

A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06044233 Org: User:
Start: 09/28/23 End: 11/08/23 Due: 11/08/24